Stock Comparison
AMGN vs JNJ
Amgen Inc and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$222.66B
$626.01B
P/E (TTM)
25.6
30.1
Forward P/E
18.4
22.3
Price/Sales
5.9
6.4
Price/Book
19.1
7.4
EV/EBITDA
15.1
19.3
Dividend Yield
2.35%
2.00%
Profitability
Net Margin
20.95%
21.83%
Operating Margin
31.63%
26.87%
Return on Equity
91.50%
25.70%
Return on Assets
8.67%
8.60%
Growth (YoY)
Revenue Growth
9.50%
6.60%
Earnings Growth
64.90%
-0.90%
Price & Risk
Beta
0.4
0.2
52-Week High
$417.84
$267.34
52-Week Low
$265.41
$170.46
Analyst Target
$374.69
$272.50
Compare AMGN and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.